AMOXICILLIN ANHYDROUS/TU - Search Results

Year	Number of Results
1972	1
1973	1
1974	15
1975	44
1976	40
1977	74
1978	49
1979	77
1980	53
1981	66
1982	103
1983	86
1984	90
1985	162
1986	101
1987	96
1988	111
1989	150
1990	131
1991	135
1992	182
1993	191
1994	191
1995	215
1996	250
1997	239
1998	331
1999	268
2000	288
2001	290
2002	298
2003	256
2004	267
2005	310
2006	273
2007	314
2008	329
2009	275
2010	276
2011	319
2012	304
2013	323
2014	305
2015	337
2016	310
2017	294
2018	259
2019	260
2020	249
2021	211
2022	225
2023	219
2024	213
2025	233
2026	160

1

Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract Infection.

Puttagunta S, Aronin SI, Gupta J, Das AF, Gupta K, Dunne MW. Puttagunta S, et al. NEJM Evid. 2025 Jul;4(7):EVIDoa2400414. doi: 10.1056/EVIDoa2400414. Epub 2025 Jun 24. NEJM Evid. 2025. PMID: 40552968 Clinical Trial.

2

Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial.

Hu Y, Zhang ZY, Wang F, Zhuang K, Xu X, Liu DS, Fan HZ, Yang L, Jiang K, Zhang DK, Xu L, Tang JH, Liu XM, He C, Shu X, Xie Y, Lau JYW, Zhu Y, Du YQ, Graham DY, Lu NH. Hu Y, et al. Lancet Microbe. 2025 Mar;6(3):100975. doi: 10.1016/j.lanmic.2024.100975. Epub 2024 Dec 18. Lancet Microbe. 2025. PMID: 39708826 Free article. Clinical Trial.

3

Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults.

Savage TJ, Butler AM, Kronman MP, Durkin MJ, Sreedhara SK, Kabbani S, Hicks LA, Huybrechts KF. Savage TJ, et al. JAMA. 2026 May 19;335(19):1694-1705. doi: 10.1001/jama.2025.26902. JAMA. 2026. PMID: 41999289 Free PMC article.

4

Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis.

Kanu JE, Soldera J. Kanu JE, et al. World J Gastroenterol. 2024 Mar 7;30(9):1213-1223. doi: 10.3748/wjg.v30.i9.1213. World J Gastroenterol. 2024. PMID: 38577188 Free PMC article.

5

Severe hepatic cholestasis after treatment with amoxicillin/clavulanic acid.

Meier M, Eriksen PL. Meier M, et al. Ugeskr Laeger. 2024 May 20;186(21):V02240094. doi: 10.61409/V02240094. Ugeskr Laeger. 2024. PMID: 38847310 Free article. Danish.

6

Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial.

Dinh A, Duran C, Ropers J, Bouchand F, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia short treatment (PTC) study group. Dinh A, et al. Clin Microbiol Infect. 2024 Aug;30(8):1020-1028. doi: 10.1016/j.cmi.2024.05.003. Epub 2024 May 9. Clin Microbiol Infect. 2024. PMID: 38734138 Free article. Clinical Trial.

7

Topical or oral antibiotics in childhood acute otitis media and ear discharge: a randomized controlled non-inferiority trial.

Hullegie S, Damoiseaux RAMJ, Hay AD, Zuithoff NPA, van Dongen TMA, Little P, Schilder AGM, Venekamp RP. Hullegie S, et al. Fam Pract. 2024 Oct 8;41(5):857-861. doi: 10.1093/fampra/cmae034. Fam Pract. 2024. PMID: 38912621 Free PMC article. Clinical Trial.

8

Vonoprazan and amoxicillin dual therapy for 14 days as the first-line treatment of Helicobacter pylori infection: A non-inferiority, randomized clinical trial.

Hu Y, Huang XH, Zhou B, Liu ML, Liu YF, Yu T, Sun P, Tan BB, Hu Y, Cheng F, Pan XL, Hong JB, Shu X, Zhu Y, Lu NH. Hu Y, et al. Helicobacter. 2024 Jan-Feb;29(1):e13045. doi: 10.1111/hel.13045. Helicobacter. 2024. PMID: 39191423 Clinical Trial.

9

Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which's better?

Yang XE, Zhang SJ, Liu Y, Yao SY, Zhang SX, Liu XM, Liang LX, Wang F. Yang XE, et al. World J Gastroenterol. 2025 Apr 7;31(13):100863. doi: 10.3748/wjg.v31.i13.100863. World J Gastroenterol. 2025. PMID: 40248055 Free PMC article. Clinical Trial.

10

Saccharomyces boulardii CNCM I-745 mitigates antibiotic-induced gut microbiome functional alterations independently of the host.

Huang Z, Brot L, Fatouh R, Bredon M, Creusot L, Lefèvre A, Lamazière A, Lefevre JH, Emond P, Planchais J, Roux X, Sokol H, Rolhion N. Huang Z, et al. Gut Microbes. 2025 Dec 31;17(1):2575924. doi: 10.1080/19490976.2025.2575924. Epub 2025 Nov 7. Gut Microbes. 2025. PMID: 41200858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,202 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,202 results

Results by year